Topical ocular (rabbit, dog); intravenous (rat)
“Alcon completed 6-month repeated dose ocular GLP toxicity studies in rabbits (Study AR-15512-AS03) and dogs (Study AR-15512-AS04) and 28-day repeated dose intravenous GLP toxicity studies in rats (Study STF-G10986 AVX-012).”
✓ VerifiedFDA integrated review, p. 80Source ↗